Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Teva Pharmaceuticals USA

Teva Pharmaceuticals USA Recalls

All product recalls associated with Teva Pharmaceuticals USA.

Get alerts for this brand

Recall Summary

Total Recalls

265

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–60 of 265 recalls

Norepinephrine Bitartrate (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility

Class IIModerate

FDADec 31, 2021MS, OH, TN• Teva Pharmaceuticals USA

MethylPREDNISolone Acetate (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility

Class IIModerate

FDADec 31, 2021MS, OH, TN• Teva Pharmaceuticals USA

Penicillin V Potassium Solution (Teva) – Subpotent (2021)

Subpotent

Class IIModerate

FDADec 16, 2021Nationwide

1 234 5...14

Page 3 of 14Next

• Teva Pharmaceuticals USA

Brinzolamide Suspension (Teva) – Defective Container (2021)

Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.

Class IIModerate

FDADec 8, 2021Nationwide• Teva Pharmaceuticals USA

Clonidine Transdermal System (Teva) – Failed Impurities (2021)

Failed Impurities/Degradation Specifications

Class IIILow

FDAOct 28, 2021Nationwide• Teva Pharmaceuticals USA

Cartia XT Diltiazem Capsules (Teva) – Incorrect Expiration Date (2021)

Labelling: Incorrect Exp. Date

Class IIModerate

FDAOct 27, 2021Nationwide• Teva Pharmaceuticals USA

AirDuo Digihaler 232/14 (Teva) – Subpotent Salmeterol (2021)

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Class IIModerate

FDASep 22, 2021Nationwide• Teva Pharmaceuticals USA

AirDuo Digihaler 232/14 (Teva) – Subpotent Salmeterol (2021)

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Class IIModerate

FDASep 22, 2021Nationwide• Teva Pharmaceuticals USA

AirDuo Digihaler 55/14 (Teva) – Subpotent Salmeterol (2021)

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Class IIModerate

FDASep 22, 2021Nationwide• Teva Pharmaceuticals USA

AirDuo Digihaler 113/14 (Teva) – Subpotent Salmeterol (2021)

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Class IIModerate

FDASep 22, 2021Nationwide• Teva Pharmaceuticals USA

AirDuo Digihaler 113/14 (Teva) – Subpotent Salmeterol (2021)

Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol

Class IIModerate

FDASep 22, 2021Nationwide• Teva Pharmaceuticals USA

Amikacin Sulfate Injection (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

DAUNOrubicin Hydrochloride (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Idarubicin Hydrochloride (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Haloperidol Decanoate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Octreotide Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Leucovorin Calcium (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Cyclobenzaprine Hydrochloride Tablets (Teva) – Microbial Contamination (2021)

CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Octreotide Acetate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA

Norepinephrine Bitartrate (Teva) – Sterility Concern (2021)

Lack of Assurance of Sterility

Class IIModerate

FDAJul 29, 2021Nationwide• Teva Pharmaceuticals USA